Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000325906 | SCV000340108 | likely benign | not specified | 2016-03-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000877910 | SCV001020723 | benign | Congenital primary aphakia; Anterior segment dysgenesis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374472 | SCV002683708 | likely benign | Cardiovascular phenotype | 2019-01-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV002509349 | SCV002818743 | likely benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ce |
RCV002509349 | SCV004009843 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | FOXE3: BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000325906 | SCV004038984 | likely benign | not specified | 2023-08-10 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003485570 | SCV004240697 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002509349 | SCV004564711 | likely benign | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing |